share_log

Needham Reiterates Buy on Cara Therapeutics, Maintains $5 Price Target

Moomoo 24/7 ·  Mar 28 05:40

Needham analyst Joseph Stringer reiterates Cara Therapeutics (NASDAQ:CARA) with a Buy and maintains $5 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment